25 XP   0   0   10

Botanix Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Botanix Pharmaceuticals Ltd together

PenkeI guess you are interested in Botanix Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Botanix Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Botanix Pharmaceuticals Ltd

I send you an email if I find something interesting about Botanix Pharmaceuticals Ltd.

Quick analysis of Botanix Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.05
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$0.04
Return On Investment
19.0%

For what price can you sell your share?

Current Price per Share
A$0.22
Expected price per share
A$0.21 - A$0.24
How sure are you?
50%

1. Valuation of Botanix Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.22

Intrinsic Value Per Share

A$-0.11 - A$-0.06

Total Value Per Share

A$-0.09 - A$-0.05

2. Growth of Botanix Pharmaceuticals Ltd (5 min.)




Is Botanix Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$14.9m$5.2m$9.6m64.5%

How much money is Botanix Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$5.9m-$8.5m$2.6m43.9%
Net Profit Margin-1,000.5%-478.1%--

How much money comes from the company's main activities?

3. Financial Health of Botanix Pharmaceuticals Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd? (5 min.)

Welcome investor! Botanix Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Botanix Pharmaceuticals Ltd.

What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd?

First you should know what it really means to hold a share of Botanix Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Botanix Pharmaceuticals Ltd is A$0.215. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Botanix Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Botanix Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Botanix Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-1.8%0.00-1.8%-0.01-2.5%0.00-2.3%0.00-1.5%
Usd Book Value Change Per Share0.012.8%0.012.8%-0.01-2.4%0.000.3%0.000.5%
Usd Dividend Per Share0.000.3%0.000.3%0.013.9%0.002.1%0.001.1%
Usd Total Gains Per Share0.013.1%0.013.1%0.001.5%0.012.4%0.001.6%
Usd Price Per Share0.08-0.08-0.04-0.06-0.04-
Price to Earnings Ratio-22.37--22.37--6.82--17.46--17.45-
Price-to-Total Gains Ratio12.71-12.71-11.73--7.40-2.12-
Price to Book Ratio8.92-8.92-11.01-97.89-54.62-
Price-to-Total Gains Ratio12.71-12.71-11.73--7.40-2.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1397285
Number of shares7156
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.01
Gains per Quarter (7156 shares)47.5836.87
Gains per Year (7156 shares)190.32147.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11617518013216137
23135037026331284
34752456039547431
46269975052763578
57887494065979725
6931049113079094872
7109122313209221101019
81241398151010541261166
91401573170011861421313
101551748189013171571460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%3.029.03.08.6%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%14.021.00.040.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%3.00.02.060.0%3.00.07.030.0%7.00.028.020.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%16.019.00.045.7%

Fundamentals of Botanix Pharmaceuticals Ltd

About Botanix Pharmaceuticals Ltd

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in Leederville, Australia.

Fundamental data was last updated by Penke on 2024-04-10 00:38:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Botanix Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Botanix Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -1,000.5% means that $-10.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -1,000.5%. The company is making a huge loss. -2
  • The TTM is -1,000.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,000.5%TTM-1,000.5%0.0%
TTM-1,000.5%YOY-478.1%-522.4%
TTM-1,000.5%5Y-2,100.0%+1,099.6%
5Y-2,100.0%10Y-2,784.2%+684.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,000.5%-200.1%-800.4%
TTM-1,000.5%-216.8%-783.7%
YOY-478.1%-288.3%-189.8%
5Y-2,100.0%-449.1%-1,650.9%
10Y-2,784.2%-605.5%-2,178.7%
1.1.2. Return on Assets

Shows how efficient Botanix Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -36.9% Return on Assets means that Botanix Pharmaceuticals Ltd generated $-0.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -36.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -36.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.9%TTM-36.9%0.0%
TTM-36.9%YOY-93.8%+57.0%
TTM-36.9%5Y-108.0%+71.1%
5Y-108.0%10Y-85.0%-23.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.9%-13.3%-23.6%
TTM-36.9%-12.8%-24.1%
YOY-93.8%-11.7%-82.1%
5Y-108.0%-13.9%-94.1%
10Y-85.0%-15.7%-69.3%
1.1.3. Return on Equity

Shows how efficient Botanix Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -39.9% Return on Equity means Botanix Pharmaceuticals Ltd generated $-0.40 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -39.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -39.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.9%TTM-39.9%0.0%
TTM-39.9%YOY-161.6%+121.7%
TTM-39.9%5Y-611.9%+572.1%
5Y-611.9%10Y-340.2%-271.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.9%-16.9%-23.0%
TTM-39.9%-16.1%-23.8%
YOY-161.6%-15.1%-146.5%
5Y-611.9%-19.3%-592.6%
10Y-340.2%-20.2%-320.0%

1.2. Operating Efficiency of Botanix Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Botanix Pharmaceuticals Ltd is operating .

  • Measures how much profit Botanix Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • An Operating Margin of -1,398.5% means the company generated $-13.98  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -1,398.5%. The company is operating very inefficient. -2
  • The TTM is -1,398.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,398.5%TTM-1,398.5%0.0%
TTM-1,398.5%YOY-578.7%-819.8%
TTM-1,398.5%5Y-2,237.5%+839.0%
5Y-2,237.5%10Y-2,616.7%+379.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,398.5%-296.2%-1,102.3%
TTM-1,398.5%-232.5%-1,166.0%
YOY-578.7%-298.2%-280.5%
5Y-2,237.5%-492.1%-1,745.4%
10Y-2,616.7%-632.4%-1,984.3%
1.2.2. Operating Ratio

Measures how efficient Botanix Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 14.98 means that the operating costs are $14.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 14.985. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.985. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.985TTM14.9850.000
TTM14.985YOY5.787+9.198
TTM14.9855Y44.198-29.213
5Y44.19810Y51.859-7.662
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.9853.231+11.754
TTM14.9853.310+11.675
YOY5.7873.890+1.897
5Y44.1985.739+38.459
10Y51.8597.876+43.983

1.3. Liquidity of Botanix Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.42 means the company has $7.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 7.416. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.416. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.416TTM7.4160.000
TTM7.416YOY1.784+5.632
TTM7.4165Y9.827-2.411
5Y9.82710Y10.394-0.567
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4163.890+3.526
TTM7.4164.173+3.243
YOY1.7845.344-3.560
5Y9.8276.126+3.701
10Y10.3946.448+3.946
1.3.2. Quick Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 5.70 means the company can pay off $5.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 5.697. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.697. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.697TTM5.6970.000
TTM5.697YOY1.262+4.436
TTM5.6975Y9.376-3.679
5Y9.37610Y10.156-0.780
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6973.514+2.183
TTM5.6973.998+1.699
YOY1.2625.380-4.118
5Y9.3766.105+3.271
10Y10.1566.404+3.752

1.4. Solvency of Botanix Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Botanix Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Botanix Pharmaceuticals Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Botanix Pharmaceuticals Ltd assets are financed with 7.6% credit (debt) and the remaining percentage (100% - 7.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 0.076. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.076. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.0760.000
TTM0.076YOY0.419-0.343
TTM0.0765Y0.299-0.223
5Y0.29910Y0.199+0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0760.339-0.263
TTM0.0760.336-0.260
YOY0.4190.271+0.148
5Y0.2990.366-0.067
10Y0.1990.389-0.190
1.4.2. Debt to Equity Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.2% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 0.082. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.082. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.082TTM0.0820.000
TTM0.082YOY0.722-0.640
TTM0.0825Y1.676-1.594
5Y1.67610Y0.893+0.783
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0820.388-0.306
TTM0.0820.402-0.320
YOY0.7220.335+0.387
5Y1.6760.426+1.250
10Y0.8930.461+0.432

2. Market Valuation of Botanix Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Botanix Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A PE ratio of -22.37 means the investor is paying $-22.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is -36.995. Based on the earnings, the company is expensive. -2
  • The MRQ is -22.369. Based on the earnings, the company is expensive. -2
  • The TTM is -22.369. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-36.995MRQ-22.369-14.626
MRQ-22.369TTM-22.3690.000
TTM-22.369YOY-6.817-15.552
TTM-22.3695Y-17.459-4.911
5Y-17.45910Y-17.448-0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-36.995-2.264-34.731
MRQ-22.369-2.629-19.740
TTM-22.369-2.680-19.689
YOY-6.817-4.145-2.672
5Y-17.459-6.257-11.202
10Y-17.448-6.254-11.194
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is -17.705. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.705. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.705. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.705MRQ-10.705-7.000
MRQ-10.705TTM-10.7050.000
TTM-10.705YOY-6.365-4.340
TTM-10.7055Y-16.897+6.191
5Y-16.89710Y-579.936+563.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.705-2.973-14.732
MRQ-10.705-3.333-7.372
TTM-10.705-3.553-7.152
YOY-6.365-5.605-0.760
5Y-16.897-8.376-8.521
10Y-579.936-8.865-571.071
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Botanix Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.92 means the investor is paying $8.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is 14.756. Based on the equity, the company is expensive. -2
  • The MRQ is 8.922. Based on the equity, the company is overpriced. -1
  • The TTM is 8.922. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD14.756MRQ8.922+5.834
MRQ8.922TTM8.9220.000
TTM8.922YOY11.014-2.092
TTM8.9225Y97.890-88.968
5Y97.89010Y54.619+43.271
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD14.7561.896+12.860
MRQ8.9222.115+6.807
TTM8.9222.093+6.829
YOY11.0142.884+8.130
5Y97.8903.542+94.348
10Y54.6193.916+50.703
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Botanix Pharmaceuticals Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Botanix Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0090.0090%-0.008+185%0.001+1010%0.002+481%
Book Value Per Share--0.0150.0150%0.005+182%0.010+51%0.007+120%
Current Ratio--7.4167.4160%1.784+316%9.827-25%10.394-29%
Debt To Asset Ratio--0.0760.0760%0.419-82%0.299-75%0.199-62%
Debt To Equity Ratio--0.0820.0820%0.722-89%1.676-95%0.893-91%
Dividend Per Share--0.0010.0010%0.013-94%0.007-88%0.004-76%
Eps---0.006-0.0060%-0.008+44%-0.008+30%-0.005-14%
Free Cash Flow Per Share---0.012-0.0120%-0.009-26%-0.008-30%-0.005-56%
Free Cash Flow To Equity Per Share--0.0020.0020%-0.009+591%-0.001+150%0.001+164%
Gross Profit Margin--1.1461.1460%1.337-14%1.367-16%1.352-15%
Intrinsic Value_10Y_max---0.061--------
Intrinsic Value_10Y_min---0.106--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.009--------
Intrinsic Value_3Y_max---0.017--------
Intrinsic Value_3Y_min---0.029--------
Intrinsic Value_5Y_max---0.029--------
Intrinsic Value_5Y_min---0.050--------
Market Cap338655093.120+40%204768195.840204768195.8400%89782978.176+128%153103604.890+34%108259370.001+89%
Net Profit Margin---10.005-10.0050%-4.781-52%-21.000+110%-27.842+178%
Operating Margin---13.985-13.9850%-5.787-59%-22.375+60%-26.167+87%
Operating Ratio--14.98514.9850%5.787+159%44.198-66%51.859-71%
Pb Ratio14.756+40%8.9228.9220%11.014-19%97.890-91%54.619-84%
Pe Ratio-36.995-65%-22.369-22.3690%-6.817-70%-17.459-22%-17.448-22%
Price Per Share0.215+40%0.1300.1300%0.057+128%0.097+34%0.069+89%
Price To Free Cash Flow Ratio-17.705-65%-10.705-10.7050%-6.365-41%-16.897+58%-579.936+5317%
Price To Total Gains Ratio21.015+40%12.70712.7070%11.730+8%-7.401+158%2.116+501%
Quick Ratio--5.6975.6970%1.262+352%9.376-39%10.156-44%
Return On Assets---0.369-0.3690%-0.938+155%-1.080+193%-0.850+131%
Return On Equity---0.399-0.3990%-1.616+305%-6.119+1434%-3.402+753%
Total Gains Per Share--0.0100.0100%0.005+111%0.008+29%0.005+98%
Usd Book Value--14915872.44714915872.4470%5297839.872+182%9898614.812+51%6793407.300+120%
Usd Book Value Change Per Share--0.0060.0060%-0.005+185%0.001+1010%0.001+481%
Usd Book Value Per Share--0.0090.0090%0.003+182%0.006+51%0.004+120%
Usd Dividend Per Share--0.0010.0010%0.008-94%0.005-88%0.002-76%
Usd Eps---0.004-0.0040%-0.005+44%-0.005+30%-0.003-14%
Usd Free Cash Flow---12431147.472-12431147.4720%-9167440.658-26%-8684309.677-30%-5450224.525-56%
Usd Free Cash Flow Per Share---0.008-0.0080%-0.006-26%-0.006-30%-0.003-56%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.006+591%-0.001+150%0.000+164%
Usd Market Cap220091945.019+40%133078850.476133078850.4760%58349957.517+128%99502032.818+34%70357764.563+89%
Usd Price Per Share0.140+40%0.0840.0840%0.037+128%0.063+34%0.045+89%
Usd Profit---5949167.703-5949167.7030%-8559669.775+44%-7725991.573+30%-5139325.623-14%
Usd Revenue--594640.953594640.9530%1790367.267-67%2381970.847-75%1211961.596-51%
Usd Total Gains Per Share--0.0070.0070%0.003+111%0.005+29%0.003+98%
 EOD+6 -2MRQTTM+0 -0YOY+25 -115Y+25 -1110Y+22 -14

4.2. Fundamental Score

Let's check the fundamental score of Botanix Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-36.995
Price to Book Ratio (EOD)Between0-114.756
Net Profit Margin (MRQ)Greater than0-10.005
Operating Margin (MRQ)Greater than0-13.985
Quick Ratio (MRQ)Greater than15.697
Current Ratio (MRQ)Greater than17.416
Debt to Asset Ratio (MRQ)Less than10.076
Debt to Equity Ratio (MRQ)Less than10.082
Return on Equity (MRQ)Greater than0.15-0.399
Return on Assets (MRQ)Greater than0.05-0.369
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Botanix Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.143
Ma 20Greater thanMa 500.221
Ma 50Greater thanMa 1000.200
Ma 100Greater thanMa 2000.186
OpenGreater thanClose0.220
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets24,836
Total Liabilities1,885
Total Stockholder Equity22,951
 As reported
Total Liabilities 1,885
Total Stockholder Equity+ 22,951
Total Assets = 24,836

Assets

Total Assets24,836
Total Current Assets13,979
Long-term Assets10,857
Total Current Assets
Cash And Cash Equivalents 10,250
Net Receivables 489
Inventory 3,147
Other Current Assets 92
Total Current Assets  (as reported)13,979
Total Current Assets  (calculated)13,979
+/-0
Long-term Assets
Property Plant Equipment 65
Intangible Assets 10,729
Other Assets 3,937
Long-term Assets  (as reported)10,857
Long-term Assets  (calculated)14,732
+/- 3,874

Liabilities & Shareholders' Equity

Total Current Liabilities1,885
Long-term Liabilities0
Total Stockholder Equity22,951
Total Current Liabilities
Accounts payable 1,391
Other Current Liabilities 494
Total Current Liabilities  (as reported)1,885
Total Current Liabilities  (calculated)1,885
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock93,490
Retained Earnings -76,922
Accumulated Other Comprehensive Income 6,383
Total Stockholder Equity (as reported)22,951
Total Stockholder Equity (calculated)22,951
+/-0
Other
Capital Stock93,490
Cash and Short Term Investments 10,250
Common Stock Shares Outstanding 1,153,952
Liabilities and Stockholders Equity 24,836
Net Debt -10,250
Net Invested Capital 22,951
Net Tangible Assets 16,096
Net Working Capital 12,094
Property Plant and Equipment Gross 65



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
24,064
25,584
27,413
25,921
38,030
48,565
68,158
57,046
50,262
30,362
16,149
5,268
5,864
4,505
2,938
2,426
3,680
2,508
3,500
2,368
2,017
59
43
18
8
2,553
1,321
3,697
5,907
17,710
5,200
25,311
21,950
14,037
24,836
24,83614,03721,95025,3115,20017,7105,9073,6971,3212,55381843592,0172,3683,5002,5083,6802,4262,9384,5055,8645,26816,14930,36250,26257,04668,15848,56538,03025,92127,41325,58424,064
   > Total Current Assets 
9,575
10,976
13,616
14,631
21,568
28,161
41,982
26,328
28,854
17,437
8,840
5,268
5,864
3,034
923
2,245
1,707
525
1,522
396
50
52
40
18
8
2,553
1,321
3,697
5,907
17,710
5,188
24,777
21,610
10,501
13,979
13,97910,50121,61024,7775,18817,7105,9073,6971,3212,5538184052503961,5225251,7072,2459233,0345,8645,2688,84017,43728,85426,32841,98228,16121,56814,63113,61610,9769,575
       Cash And Cash Equivalents 
399
185
718
446
2,076
4,224
5,306
4,551
3,898
4,571
1,605
4,390
5,826
2,964
878
1,307
1,679
221
1,479
373
10
33
7
10
1
2,513
1,309
3,652
5,721
17,263
4,704
24,645
21,555
7,286
10,250
10,2507,28621,55524,6454,70417,2635,7213,6521,3092,513110733103731,4792211,6791,3078782,9645,8264,3901,6054,5713,8984,5515,3064,2242,076446718185399
       Short-term Investments 
0
0
0
1,395
1,269
1,751
2,044
3,661
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
0
0
0
00000200000000000000000000003,6612,0441,7511,2691,395000
       Net Receivables 
4,038
4,460
5,868
6,554
8,313
11,094
18,422
11,148
10,576
7,910
4,585
690
38
53
36
939
28
305
44
23
19
13
10
7
7
30
10
38
163
427
483
131
45
141
489
48914145131483427163381030771013192344305289393653386904,5857,91010,57611,14818,42211,0948,3136,5545,8684,4604,038
       Inventory 
5,108
6,285
7,014
6,225
9,904
11,086
16,197
6,949
10,377
3,844
2,644
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,044
3,044
3,147
3,1473,0443,0440000000000000000000002,6443,84410,3776,94916,19711,0869,9046,2257,0146,2855,108
       Other Current Assets 
30
46
16
11
6
6
13
19
4,003
1,112
6
188
0
17
9
0
0
0
0
0
21
6
23
0
0
11
2
7
24
20
0
1
10
30
92
9230101020247211002362100000917018861,1124,00319136611164630
   > Long-term Assets 
14,489
14,608
13,797
11,290
16,462
20,404
26,176
30,718
21,408
12,925
7,309
0
0
1,471
2,015
181
1,973
1,983
1,978
1,972
1,967
6
2
0
0
0
0
0
0
0
12
534
340
3,536
10,857
10,8573,536340534120000000261,9671,9721,9781,9831,9731812,0151,471007,30912,92521,40830,71826,17620,40416,46211,29013,79714,60814,489
       Property Plant Equipment 
8,081
7,471
9,217
8,351
12,430
14,930
19,714
19,790
14,650
12,768
7,118
0
0
186
113
181
12
26
21
16
10
6
2
0
0
0
0
0
0
0
12
445
278
179
65
65179278445120000000261016212612181113186007,11812,76814,65019,79019,71414,93012,4308,3519,2177,4718,081
       Goodwill 
1,585
1,501
1,419
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961
1,957
1,957
1,957
1,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,9571,9571,9571,9571,96100000000000001,4191,5011,585
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
62
62
0
06262890000000000000000000000000000000
       Intangible Assets 
600
680
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961
1,957
1,957
1,957
1,957
1,957
0
0
0
0
0
0
0
0
0
0
3,295
3,295
10,729
10,7293,2953,29500000000001,9571,9571,9571,9571,9571,96100000000000000680600
       Long-term Assets Other 
3,949
4,491
2,584
2,016
2,621
4,163
4,210
7,718
6,420
157
68
0
0
1,286
28
179
0
0
0
0
0
-1,957
0
0
0
0
0
0
0
0
-89
0
-278
-3,475
-6,921
-6,921-3,475-2780-8900000000-1,95700000179281,28600681576,4207,7184,2104,1632,6212,0162,5844,4913,949
> Total Liabilities 
11,819
13,623
14,538
14,515
19,684
22,521
29,718
19,133
18,216
14,610
8,065
118
169
458
289
182
223
284
603
1,082
1,139
1,855
2,274
2,352
2,509
310
92
516
471
1,426
4,585
1,674
1,150
5,886
1,885
1,8855,8861,1501,6744,5851,426471516923102,5092,3522,2741,8551,1391,0826032842231822894581691188,06514,61018,21619,13329,71822,52119,68414,51514,53813,62311,819
   > Total Current Liabilities 
9,293
10,832
11,697
11,431
15,821
18,245
25,066
12,778
17,256
13,963
7,508
118
169
443
275
182
222
284
603
1,082
1,139
971
886
2,352
2,509
310
92
516
471
1,426
4,585
1,378
1,038
5,886
1,885
1,8855,8861,0381,3784,5851,426471516923102,5092,3528869711,1391,0826032842221822754431691187,50813,96317,25612,77825,06618,24515,82111,43111,69710,8329,293
       Short-term Debt 
0
0
0
1,395
1,269
1,751
2,044
3,661
0
0
0
0
0
0
0
0
1
0
0
0
0
0
58
477
428
0
0
0
0
0
124
124
147
122
0
01221471241240000042847758000001000000003,6612,0441,7511,2691,395000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
118
0
0
62
0
194
94
275
148
332
137
134
259
205
280
33
456
454
911
4,485
1,177
652
4,682
1,391
1,3914,6826521,1774,48591145445633280205259134137332148275941940620011800000000000
       Other Current Liabilities 
7,430
9,177
9,271
7,253
9,705
10,360
10,203
2,991
8,549
5,318
2,252
0
0
343
213
0
27
190
328
933
807
835
695
1,615
1,876
30
33
60
17
515
100
77
239
1,081
494
4941,08123977100515176033301,8761,615695835807933328190270213343002,2525,3188,5492,99110,20310,3609,7057,2539,2719,1777,430
   > Long-term Liabilities 
2,526
2,791
2,841
3,084
3,863
4,276
4,652
6,355
960
647
557
0
0
15
15
0
1
0
0
0
0
884
1,388
0
0
0
0
0
0
0
296
296
112
5,790
0
05,79011229629600000001,3888840000101515005576479606,3554,6524,2763,8633,0842,8412,7912,526
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
296
112
0
0
001122960000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
15
15
0
0
0
0
0
0
884
1,388
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,38888400000015150000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,874
3,8740000000000000000000000000000000000
> Total Stockholder Equity
12,245
11,961
12,875
11,406
18,346
26,044
38,440
37,913
32,046
15,752
8,084
5,150
5,695
4,047
2,649
2,245
3,430
2,224
2,897
1,286
878
-1,797
-2,231
-2,334
-2,501
2,244
1,229
3,181
5,437
16,285
615
23,637
20,800
8,152
22,951
22,9518,15220,80023,63761516,2855,4373,1811,2292,244-2,501-2,334-2,231-1,7978781,2862,8972,2243,4302,2452,6494,0475,6955,1508,08415,75232,04637,91338,44026,04418,34611,40612,87511,96112,245
   Common Stock
8,266
8,266
8,266
8,841
9,013
12,513
19,623
19,625
22,512
22,512
35,926
36,601
37,499
37,261
37,261
37,816
68,766
7,475
12,233
13,447
15,970
17,194
18,228
19,704
21,372
25,658
25,658
4,717
11,632
33,299
33,890
71,414
71,476
71,476
93,490
93,49071,47671,47671,41433,89033,29911,6324,71725,65825,65821,37219,70418,22817,19415,97013,44712,2337,47568,76637,81637,26137,26137,49936,60135,92622,51222,51219,62519,62312,5139,0138,8418,2668,2668,266
   Retained Earnings 
625
326
1,226
-540
1,153
3,621
7,303
8,799
-3,875
-20,945
-28,153
-31,325
-31,804
-33,214
-34,613
-35,571
-65,336
-6,360
-9,777
-12,602
-15,646
-19,591
-21,111
-22,214
-24,064
-25,195
-26,209
-1,708
-6,481
-17,493
-34,532
-51,263
-54,597
-67,768
-76,922
-76,922-67,768-54,597-51,263-34,532-17,493-6,481-1,708-26,209-25,195-24,064-22,214-21,111-19,591-15,646-12,602-9,777-6,360-65,336-35,571-34,613-33,214-31,804-31,325-28,153-20,945-3,8758,7997,3033,6211,153-5401,226326625
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
3,354
3,369
3,383
9,642
16,708
21,009
25,794
27,010
35,723
39,420
26,331
0
0
37
0
0
0
0
0
0
0
0
0
0
0
0
0
6
286
479
1,258
-20,151
-16,879
-3,708
-16,568
-16,568-3,708-16,879-20,1511,25847928660000000000000370026,33139,42035,72327,01025,79421,00916,7089,6423,3833,3693,354



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue915
Cost of Revenue-3,961
Gross Profit-3,046-3,046
 
Operating Income (+$)
Gross Profit-3,046
Operating Expense-9,750
Operating Income-12,796-12,796
 
Operating Expense (+$)
Research Development5,727
Selling General Administrative2,682
Selling And Marketing Expenses1,340
Operating Expense9,7509,750
 
Net Interest Income (+$)
Interest Income94
Interest Expense-82
Other Finance Cost-28
Net Interest Income-16
 
Pretax Income (+$)
Operating Income-12,796
Net Interest Income-16
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,823-12,768
EBIT - interestExpense = -12,878
-12,823
-9,072
Interest Expense82
Earnings Before Interest and Taxes (EBIT)-12,796-12,742
Earnings Before Interest and Taxes (EBITDA)-12,685
 
After tax Income (+$)
Income Before Tax-12,823
Tax Provision-0
Net Income From Continuing Ops-9,154-12,823
Net Income-9,154
Net Income Applicable To Common Shares-9,154
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,711
Total Other Income/Expenses Net-2816
 

Technical Analysis of Botanix Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Botanix Pharmaceuticals Ltd. The general trend of Botanix Pharmaceuticals Ltd is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Botanix Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Botanix Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.24 < 0.24 < 0.24.

The bearish price targets are: 0.21 > 0.21 > 0.21.

Tweet this
Botanix Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Botanix Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Botanix Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Botanix Pharmaceuticals Ltd. The current macd is 0.00523592.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Botanix Pharmaceuticals Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Botanix Pharmaceuticals Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Botanix Pharmaceuticals Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Botanix Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBotanix Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Botanix Pharmaceuticals Ltd. The current adx is 32.03.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Botanix Pharmaceuticals Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Botanix Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Botanix Pharmaceuticals Ltd. The current sar is 0.23418117.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Botanix Pharmaceuticals Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Botanix Pharmaceuticals Ltd. The current rsi is 52.14. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Botanix Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartBotanix Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Botanix Pharmaceuticals Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Botanix Pharmaceuticals Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Botanix Pharmaceuticals Ltd Daily Stochastic Oscillator ChartBotanix Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Botanix Pharmaceuticals Ltd. The current cci is -18.42546064.

Botanix Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartBotanix Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Botanix Pharmaceuticals Ltd. The current cmo is -2.88893668.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Botanix Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartBotanix Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Botanix Pharmaceuticals Ltd. The current willr is -71.42857143.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Botanix Pharmaceuticals Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Botanix Pharmaceuticals Ltd Daily Williams %R ChartBotanix Pharmaceuticals Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Botanix Pharmaceuticals Ltd.

Botanix Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Botanix Pharmaceuticals Ltd. The current atr is 0.01098119.

Botanix Pharmaceuticals Ltd Daily Average True Range (ATR) ChartBotanix Pharmaceuticals Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Botanix Pharmaceuticals Ltd. The current obv is -8,401,880.

Botanix Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartBotanix Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Botanix Pharmaceuticals Ltd. The current mfi is 18.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Botanix Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartBotanix Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Botanix Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Botanix Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Botanix Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.143
Ma 20Greater thanMa 500.221
Ma 50Greater thanMa 1000.200
Ma 100Greater thanMa 2000.186
OpenGreater thanClose0.220
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Botanix Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Botanix Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Botanix Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Botanix Pharmaceuticals Ltd

I send you an email if I find something interesting about Botanix Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Botanix Pharmaceuticals Ltd.

Receive notifications about Botanix Pharmaceuticals Ltd in your mailbox!